Fever Without Source or Unknown Origin-Child
| Procedure | Appropriateness Category | Peds Relative Radiation Level |
| Radiography chest | May Be Appropriate | ☢ |
| US chest | Usually Not Appropriate | O |
| MRI chest without and with IV contrast | Usually Not Appropriate | O |
| MRI chest without IV contrast | Usually Not Appropriate | O |
| MRI whole body without and with IV contrast | Usually Not Appropriate | O |
| MRI whole body without IV contrast | Usually Not Appropriate | O |
| CT abdomen and pelvis with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| FDG-PET/MRI whole body | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without and with IV contrast | Usually Not Appropriate | ☢☢☢☢☢ |
| FDG-PET/CT whole body | Usually Not Appropriate | ☢☢☢☢ |
| Procedure | Appropriateness Category | Peds Relative Radiation Level |
| Radiography chest | May Be Appropriate | ☢ |
| US abdomen | Usually Not Appropriate | O |
| US kidneys and bladder | Usually Not Appropriate | O |
| MRI chest without and with IV contrast | Usually Not Appropriate | O |
| MRI chest without IV contrast | Usually Not Appropriate | O |
| MRI whole body without and with IV contrast | Usually Not Appropriate | O |
| MRI whole body without IV contrast | Usually Not Appropriate | O |
| CT paranasal sinuses with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT paranasal sinuses without IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT abdomen and pelvis with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT neck without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck without IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT paranasal sinuses without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| FDG-PET/MRI whole body | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without and with IV contrast | Usually Not Appropriate | ☢☢☢☢☢ |
| FDG-PET/CT whole body | Usually Not Appropriate | ☢☢☢☢ |
| Procedure | Appropriateness Category | Peds Relative Radiation Level |
| Radiography chest | May Be Appropriate (Disagreement) | ☢ |
| CT paranasal sinuses with IV contrast | May Be Appropriate | ☢☢☢ |
| CT paranasal sinuses without IV contrast | May Be Appropriate | ☢☢☢ |
| CT abdomen and pelvis with IV contrast | May Be Appropriate | ☢☢☢☢ |
| CT chest with IV contrast | May Be Appropriate | ☢☢☢☢ |
| CT chest without IV contrast | May Be Appropriate | ☢☢☢☢ |
| FDG-PET/MRI whole body | May Be Appropriate | ☢☢☢☢ |
| FDG-PET/CT whole body | May Be Appropriate | ☢☢☢☢ |
| US abdomen | Usually Not Appropriate | O |
| 3-phase bone scan whole body | Usually Not Appropriate | ☢☢☢☢ |
| Bone scan and WBC scan whole body | Usually Not Appropriate | ☢☢☢☢ |
| MRI abdomen and pelvis without and with IV contrast | Usually Not Appropriate | O |
| MRI abdomen and pelvis without IV contrast | Usually Not Appropriate | O |
| MRI chest without and with IV contrast | Usually Not Appropriate | O |
| MRI chest without IV contrast | Usually Not Appropriate | O |
| MRI whole body without and with IV contrast | Usually Not Appropriate | O |
| MRI whole body without IV contrast | Usually Not Appropriate | O |
| CT abdomen and pelvis without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT neck without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck without IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT paranasal sinuses without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without and with IV contrast | Usually Not Appropriate | ☢☢☢☢☢ |
| Fluoride PET/CT whole body | Usually Not Appropriate | ☢☢☢☢ |
| Procedure | Appropriateness Category | Peds Relative Radiation Level |
| Radiography chest | May Be Appropriate | ☢ |
| MRI whole body without and with IV contrast | May Be Appropriate | O |
| MRI whole body without IV contrast | May Be Appropriate | O |
| FDG-PET/MRI whole body | May Be Appropriate | ☢☢☢☢ |
| FDG-PET/CT whole body | May Be Appropriate | ☢☢☢☢ |
| US abdomen | Usually Not Appropriate | O |
| 3-phase bone scan whole body | Usually Not Appropriate | ☢☢☢☢ |
| Bone scan and WBC scan whole body | Usually Not Appropriate | ☢☢☢☢ |
| MRI chest without and with IV contrast | Usually Not Appropriate | O |
| MRI chest without IV contrast | Usually Not Appropriate | O |
| CT paranasal sinuses with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT paranasal sinuses without IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT abdomen and pelvis with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT chest without IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck with IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT neck without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT neck without IV contrast | Usually Not Appropriate | ☢☢☢ |
| CT paranasal sinuses without and with IV contrast | Usually Not Appropriate | ☢☢☢☢ |
| CT abdomen and pelvis without and with IV contrast | Usually Not Appropriate | ☢☢☢☢☢ |
| Fluoride PET/CT whole body | Usually Not Appropriate | ☢☢☢☢ |
A. CT abdomen and pelvis with IV contrast
B. CT abdomen and pelvis without and with IV contrast
C. CT abdomen and pelvis without IV contrast
D. CT chest with IV contrast
E. CT chest without and with IV contrast
F. CT chest without IV contrast
G. FDG-PET/CT whole body
H. FDG-PET/MRI whole body
I. MRI chest without and with IV contrast
J. MRI chest without IV contrast
K. MRI whole body without and with IV contrast
L. MRI whole body without IV contrast
M. Radiography chest
N. US chest
A. CT abdomen and pelvis with IV contrast
B. CT abdomen and pelvis without and with IV contrast
C. CT abdomen and pelvis without IV contrast
D. CT chest with IV contrast
E. CT chest without and with IV contrast
F. CT chest without IV contrast
G. CT neck with IV contrast
H. CT neck without and with IV contrast
I. CT neck without IV contrast
J. CT paranasal sinuses with IV contrast
K. CT paranasal sinuses without and with IV contrast
L. CT paranasal sinuses without IV contrast
M. FDG-PET/CT whole body
N. FDG-PET/MRI whole body
O. MRI chest without and with IV contrast
P. MRI chest without IV contrast
Q. MRI whole body without and with IV contrast
R. MRI whole body without IV contrast
S. Radiography chest
T. US abdomen
U. US kidneys and bladder
A. 3-phase bone scan whole body
B. Bone scan and WBC scan whole body
C. CT abdomen and pelvis with IV contrast
D. CT abdomen and pelvis without and with IV contrast
E. CT abdomen and pelvis without IV contrast
F. CT chest with IV contrast
G. CT chest without and with IV contrast
H. CT chest without IV contrast
I. CT neck with IV contrast
J. CT neck without and with IV contrast
K. CT neck without IV contrast
L. CT paranasal sinuses with IV contrast
M. CT paranasal sinuses without and with IV contrast
N. CT paranasal sinuses without IV contrast
O. FDG-PET/CT whole body
P. FDG-PET/MRI whole body
Q. Fluoride PET/CT whole body
R. MRI abdomen and pelvis without and with IV contrast
S. MRI abdomen and pelvis without IV contrast
T. MRI chest without and with IV contrast
U. MRI chest without IV contrast
V. MRI whole body without and with IV contrast
W. MRI whole body without IV contrast
X. Radiography chest
Y. US abdomen
A. 3-phase bone scan whole body
B. Bone scan and WBC scan whole body
C. CT abdomen and pelvis with IV contrast
D. CT abdomen and pelvis without and with IV contrast
E. CT abdomen and pelvis without IV contrast
F. CT chest with IV contrast
G. CT chest without and with IV contrast
H. CT chest without IV contrast
I. CT neck with IV contrast
J. CT neck without and with IV contrast
K. CT neck without IV contrast
L. CT paranasal sinuses with IV contrast
M. CT paranasal sinuses without and with IV contrast
N. CT paranasal sinuses without IV contrast
O. FDG-PET/CT whole body
P. FDG-PET/MRI whole body
Q. Fluoride PET/CT whole body
R. MRI chest without and with IV contrast
S. MRI chest without IV contrast
T. MRI whole body without and with IV contrast
U. MRI whole body without IV contrast
V. Radiography chest
W. US abdomen
The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.
For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.
|
Appropriateness Category Name |
Appropriateness Rating |
Appropriateness Category Definition |
|
Usually Appropriate |
7, 8, or 9 |
The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients. |
|
May Be Appropriate |
4, 5, or 6 |
The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal. |
|
May Be Appropriate (Disagreement) |
5 |
The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned. |
|
Usually Not Appropriate |
1, 2, or 3 |
The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable. |
Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, because of both organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared with those specified for adults (see Table below). Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria® Radiation Dose Assessment Introduction document.
|
Relative Radiation Level Designations |
||
|
Relative Radiation Level* |
Adult Effective Dose Estimate Range |
Pediatric Effective Dose Estimate Range |
|
O |
0 mSv |
0 mSv |
|
☢ |
<0.1 mSv |
<0.03 mSv |
|
☢☢ |
0.1-1 mSv |
0.03-0.3 mSv |
|
☢☢☢ |
1-10 mSv |
0.3-3 mSv |
|
☢☢☢☢ |
10-30 mSv |
3-10 mSv |
|
☢☢☢☢☢ |
30-100 mSv |
10-30 mSv |
|
*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as “Varies.” |
||
| 1. | Arora R, Mahajan P. Evaluation of child with fever without source: review of literature and update. Pediatr Clin North Am. 2013;60(5):1049-1062. | |
| 2. | Rose E. Pediatric Fever. Emerg Med Clin North Am 2021;39:627-39. | |
| 3. | Chan SS, Kotecha MK, Rigsby CK, et al. ACR Appropriateness Criteria® Pneumonia in the Immunocompetent Child. J Am Coll Radiol 2020;17:S215-S25. | |
| 4. | Karmazyn BK, Alazraki AL, Anupindi SA, et al. ACR Appropriateness Criteria® Urinary Tract Infection-Child. J Am Coll Radiol 2017;14:S362-S71. | |
| 5. | Koberlein GC, Trout AT, Rigsby CK, et al. ACR Appropriateness Criteria® Suspected Appendicitis-Child. J Am Coll Radiol 2019;16:S252-S63. | |
| 6. | Woll C, Neuman MI, Aronson PL. Management of the Febrile Young Infant: Update for the 21st Century. [Review]. Pediatric Emergency Care. 33(11):748-753, 2017 Nov. | |
| 7. | Greenhow TL, Hung YY, Herz AM, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J 2014;33:595-9. | |
| 8. | Kuppermann N, Dayan PS, Levine DA, et al. A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections. JAMA Pediatrics. 173(4):342-351, 2019 04 01. | |
| 9. | Mace AO, Martin AC, Ramsay J, Totterdell J, Marsh JA, Snelling T. FeBRILe3 Project: protocol for a prospective pragmatic, multisite observational study and safety evaluation assessing Fever, Blood cultures and Readiness for discharge in Infants Less than 3 months old. BMJ Open. 10(5):e035992, 2020 05 12. | |
| 10. | Mercurio L, Hill R, Duffy S, Zonfrillo MR. Clinical Practice Guideline Reduces Evaluation and Treatment for Febrile Infants 0 to 56 Days of Age. Clinical Pediatrics. 59(9-10):893-901, 2020 09. | |
| 11. | Woll C, Neuman MI, Pruitt CM, et al. Epidemiology and Etiology of Invasive Bacterial Infection in Infants </=60 Days Old Treated in Emergency Departments. J Pediatr 2018;200:210-17 e1. | |
| 12. | McCulloh RJ, McDaniel LM, Kerns E, Biondi EA. Prevalence of Invasive Bacterial Infections in Well-Appearing, Febrile Infants. Hospital Pediatrics. 11(9):e184-e188, 2021 09. | |
| 13. | Heulitt MJ, Ablow RC, Santos CC, O'Shea TM, Hilfer CL. Febrile infants less than 3 months old: value of chest radiography. Radiology. 1988;167(1):135-137. | |
| 14. | Ozcan A, Laskowski E, Sahai S, Levasseur K. Febrile infants without respiratory symptoms or sick contacts: are chest radiographs or RSV/influenza testing indicated?. BMC Infectious Diseases. 21(1):862, 2021 Aug 23. | |
| 15. | Biondi EA, Byington CL. Evaluation and Management of Febrile, Well-appearing Young Infants. [Review]. Infectious Disease Clinics of North America. 29(3):575-85, 2015 Sep. | |
| 16. | Pantell RH, Roberts KB, Adams WG, et al. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. Pediatrics. 148(2), 2021 08. | |
| 17. | Yaeger JP, Jones J, Ertefaie A, Caserta MT, van Wijngaarden E, Fiscella K. Refinement and Validation of a Clinical-Based Approach to Evaluate Young Febrile Infants. Hospital Pediatrics. 12(4):399-407, 2022 Apr 01. | |
| 18. | Waterfield T, Lyttle MD, Munday C, et al. Validating clinical practice guidelines for the management of febrile infants presenting to the emergency department in the UK and Ireland. Archives of Disease in Childhood. 107(4):329-334, 2022 04. | |
| 19. | Mintegi S, Bressan S, Gomez B, et al. Accuracy of a sequential approach to identify young febrile infants at low risk for invasive bacterial infection. Emergency Medicine Journal. 31(e1):e19-24, 2014 Oct. | |
| 20. | Biondi EA, McCulloh R, Staggs VS, et al. Reducing Variability in the Infant Sepsis Evaluation (REVISE): A National Quality Initiative. Pediatrics 2019;144. | |
| 21. | Cram EF BD, Bijur PE, Goldman HS. Is a Chest Radiograph Necessary in the of Every Febrile Infant Less Than 8 Evaluation Weeks of Age? Pediatrics 1991;88:821-24. | |
| 22. | Bramson RT, Meyer TL, Silbiger ML, Blickman JG, Halpern E. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics. 1993;92(4):524-526. | |
| 23. | American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Pediatric Fever, Mace SE, Gemme SR, et al. Clinical Policy for Well-Appearing Infants and Children Younger Than 2 Years of Age Presenting to the Emergency Department With Fever. Annals of Emergency Medicine. 67(5):625-639.e13, 2016 May. | |
| 24. | Antoon JW, Potisek NM, Lohr JA. Pediatric Fever of Unknown Origin. Pediatr Rev 2015;36:380-90; quiz 91. | |
| 25. | Besson FL, Chaumet-Riffaud P, Playe M, et al. Contribution of (18)F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis. [Review]. European Journal of Nuclear Medicine & Molecular Imaging. 43(10):1887-95, 2016 Sep. | |
| 26. | Williams-Smith JA, Fougere Y, Pauchard JY, Asner S, Gehri M, Crisinel PA. Risk factors for urinary tract infections in children aged 0-36months presenting with fever without source and evaluated for risk of serious bacterial infections. Archives de Pediatrie. 27(7):372-379, 2020 Oct. | |
| 27. | Hamilton JL, Evans SG, Bakshi M. Management of Fever in Infants and Young Children. American Family Physician. 101(12):721-729, 2020 06 15.Am Fam Physician. 101(12):721-729, 2020 06 15. | |
| 28. | Borensztajn D, Hagedoorn NN, Carrol E, et al. Characteristics and management of adolescents attending the ED with fever: a prospective multicentre study. BMJ Open. 12(1):e053451, 2022 01 19. | |
| 29. | Patterson RJ, Bisset GS, 3rd, Kirks DR, Vanness A. Chest radiographs in the evaluation of the febrile infant. AJR Am J Roentgenol. 1990;155(4):833-835. | |
| 30. | Lipsett SC, Hirsch AW, Monuteaux MC, Bachur RG, Neuman MI. Development of the Novel Pneumonia Risk Score to Predict Radiographic Pneumonia in Children. Pediatric Infectious Disease Journal. 41(1):24-30, 2022 01 01. | |
| 31. | Ramgopal S, Ambroggio L, Lorenz D, Shah SS, Ruddy RM, Florin TA. A Prediction Model for Pediatric Radiographic Pneumonia. Pediatrics. 149(1), 2022 01 01. | |
| 32. | Pulcini CD, Lentz S, Saladino RA, et al. Emergency management of fever and neutropenia in children with cancer: A review. [Review]. American Journal of Emergency Medicine. 50:693-698, 2021 12. | |
| 33. | Lehrnbecher T. Treatment of fever in neutropenia in pediatric oncology patients. [Review]. Current Opinion in Pediatrics. 31(1):35-40, 2019 02. | |
| 34. | Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. [Review]. Journal of Clinical Oncology. 35(18):2082-2094, 2017 Jun 20. | |
| 35. | Rao AD, Sugar EA, Barrett N, Mahesh M, Arceci RJ. The utility of computed tomography in the management of fever and neutropenia in pediatric oncology. Pediatric Blood & Cancer. 62(10):1761-7, 2015 Oct. | |
| 36. | Agrawal AK, Saini N, Gildengorin G, Feusner JH. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies? Pediatr Blood Cancer. 2011;57(4):620-624. | |
| 37. | Qiu KY, Liao XY, Huang K, et al. The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation. Clin Transplant 2019;33:e13641. | |
| 38. | Chan SS, Coblentz A, Bhatia A, et al. Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer 2023;70 Suppl 4:e30013. | |
| 39. | Weitzer F, Nazerani Hooshmand T, Pernthaler B, Sorantin E, Aigner RM. Diagnostic value of F-18 FDG PET/CT in fever or inflammation of unknown origin in a large single-center retrospective study. Scientific Reports. 12(1):1883, 2022 02 03. | |
| 40. | Wang SS, Mechinaud F, Thursky K, Cain T, Lau E, Haeusler GM. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children. Journal of Paediatrics & Child Health. 54(5):487-492, 2018 May. | |
| 41. | Blokhuis GJ, Bleeker-Rovers CP, Diender MG, Oyen WJ, Draaisma JM, de Geus-Oei LF. Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression. Eur J Nucl Med Mol Imaging. 2014;41(10):1916-1923. | |
| 42. | Yang J, Zhuang H. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients. Hellenic Journal of Nuclear Medicine. 18(2):136-9, 2015 May-Aug. | |
| 43. | Casali M, Lauri C, Altini C, et al. State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. | |
| 44. | Korones DN HM, Gullace MA. Routine Chest Radiography of Children with Cancer Hospitalized for Fever and Neutropenia Is It Really Necessary? Cancer 1997;80:1160-64. | |
| 45. | Roberts SD, Wells GM, Gandhi NM, et al. Diagnostic value of routine chest radiography in febrile, neutropenic children for early detection of pneumonia and mould infections. Support Care Cancer 2012;20:2589-94. | |
| 46. | Cox JA, DeMasi J, McCollom S, Jackson G, Scothorn D, Aquino VM. The diagnostic utility of routine chest radiography in the evaluation of the initial fever in patients undergoing hematopoietic stem cell. Pediatr Blood Cancer. 2011;57(4):666-668. | |
| 47. | Tavakoli AA, Reichert M, Blank T, et al. Findings in whole body MRI and conventional imaging in patients with fever of unknown origin-a retrospective study. BMC Medical Imaging. 20(1):94, 2020 08 07. | |
| 48. | Takeuchi M, Dahabreh IJ, Nihashi T, Iwata M, Varghese GM, Terasawa T. Nuclear Imaging for Classic Fever of Unknown Origin: Meta-Analysis. Journal of Nuclear Medicine. 57(12):1913-1919, 2016 Dec. | |
| 49. | Chamroonrat W. PET/Computed Tomography in the Evaluation of Fever of Unknown Origin and Infectious/Inflammatory Disease in Pediatric Patients. [Review]. Pet Clinics. 15(3):361-369, 2020 Jul. | |
| 50. | Kan Y, Wang W, Liu J, Yang J, Wang Z. Contribution of 18F-FDG PET/CT in a case-mix of fever of unknown origin and inflammation of unknown origin: a meta-analysis. Acta Radiologica. 60(6):716-725, 2019 Jun. | |
| 51. | Schonau V, Vogel K, Englbrecht M, et al. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Annals of the Rheumatic Diseases. 77(1):70-77, 2018 Jan. | |
| 52. | Mulders-Manders CM, Kouijzer IJ, Janssen MJ, Oyen WJ, Simon A, Bleeker-Rovers CP. Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin. The Quarterly Journal of Nuclear Medicine. 65(1):51-58, 2021 Mar. | |
| 53. | Bharucha T, Rutherford A, Skeoch S, et al. Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise. [Review]. Clinical Radiology. 72(9):764-771, 2017 Sep. | |
| 54. | Okuyucu K, Alagoz E, Demirbas S, et al. Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin. The Quarterly Journal of Nuclear Medicine. 62(3):313-320, 2018 Sep. | |
| 55. | Wang WX, Cheng ZT, Zhu JL, et al. Combined clinical parameters improve the diagnostic efficacy of 18F-FDG PET/CT in patients with fever of unknown origin (FUO) and inflammation of unknown origin (IUO): A prospective study in China. International Journal of Infectious Diseases. 93:77-83, 2020 Apr. | |
| 56. | Takeuchi M, Nihashi T, Gafter-Gvili A, et al. Association of 18F-FDG PET or PET/CT results with spontaneous remission in classic fever of unknown origin: A systematic review and meta-analysis. [Review]. Medicine. 97(43):e12909, 2018 Oct. | |
| 57. | del Rosal T, Goycochea WA, Mendez-Echevarria A, et al. (1)(8)F-FDG PET/CT in the diagnosis of occult bacterial infections in children. Eur J Pediatr. 2013;172(8):1111-1115. | |
| 58. | Pijl JP, Kwee TC, Legger GE, et al. Role of FDG-PET/CT in children with fever of unknown origin. European Journal of Nuclear Medicine & Molecular Imaging. 47(6):1596-1604, 2020 06. | |
| 59. | Purz S, Sabri O, Viehweger A, et al. Potential Pediatric Applications of PET/MR. J Nucl Med. 2014;55(Supplement 2):32S-39S. | |
| 60. | Sethi I, Baum YS, Grady EE. Current Status of Molecular Imaging of Infection: A Primer. [Review]. AJR Am J Roentgenol. 213(2):300-308, 2019 08. | |
| 61. | Schaefer JF, Berthold LD, Hahn G, et al. Whole-Body MRI in Children and Adolescents - S1 Guideline. Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 191(7):618-625, 2019 Jul. | |
| 62. | Korchi AM, Hanquinet S, Anooshiravani M, Merlini L. Whole-body magnetic resonance imaging: an essential tool for diagnosis and work up of non-oncological systemic diseases in children. Minerva Pediatrica. 66(3):169-76, 2014 Jun. | |
| 63. | Damasio MB, Magnaguagno F, Stagnaro G. Whole-body MRI: non-oncological applications in paediatrics. [Review]. Radiologia Medica. 121(5):454-61, 2016 May. | |
| 64. | National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on National Statistics; Committee on Measuring Sex, Gender Identity, and Sexual Orientation. Measuring Sex, Gender Identity, and Sexual Orientation. In: Becker T, Chin M, Bates N, eds. Measuring Sex, Gender Identity, and Sexual Orientation. Washington (DC): National Academies Press (US) Copyright 2022 by the National Academy of Sciences. All rights reserved.; 2022. | |
| 65. | American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf. |
The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.